annual EBIT:
-$451.22M-$90.30M(-25.02%)Summary
- As of today (June 23, 2025), MDGL annual earnings before interest & taxes is -$451.22 million, with the most recent change of -$90.30 million (-25.02%) on December 31, 2024.
- During the last 3 years, MDGL annual EBIT has fallen by -$209.38 million (-86.57%).
- MDGL annual EBIT is now -660.24% below its all-time high of $80.54 million, reached on December 31, 2009.
Performance
MDGL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$69.94M-$14.02M(-25.08%)Summary
- As of today (June 23, 2025), MDGL quarterly earnings before interest & taxes is -$69.94 million, with the most recent change of -$14.02 million (-25.08%) on March 31, 2025.
- Over the past year, MDGL quarterly EBIT has increased by +$73.76 million (+51.33%).
- MDGL quarterly EBIT is now -159.19% below its all-time high of $118.17 million, reached on September 30, 2009.
Performance
MDGL quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$377.46M+$73.76M(+16.35%)Summary
- As of today (June 23, 2025), MDGL TTM earnings before interest & taxes is -$377.46 million, with the most recent change of +$73.76 million (+16.35%) on March 31, 2025.
- Over the past year, MDGL TTM EBIT has increased by +$52.60 million (+12.23%).
- MDGL TTM EBIT is now -503.78% below its all-time high of $93.48 million, reached on March 31, 2010.
Performance
MDGL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MDGL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.0% | +51.3% | +12.2% |
| 3 y3 years | -86.6% | -21.6% | -52.9% |
| 5 y5 years | -375.1% | -84.0% | -228.6% |
MDGL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.6% | at low | -25.1% | +52.8% | -52.9% | +25.0% |
| 5 y | 5-year | -375.1% | at low | -84.0% | +52.8% | -228.6% | +25.0% |
| alltime | all time | -660.2% | at low | -159.2% | +52.8% | -503.8% | +25.0% |
MDGL EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$69.94M(+25.1%) | -$377.46M(-16.3%) |
| Dec 2024 | -$451.22M(+25.0%) | -$55.92M(-45.9%) | -$451.22M(-10.4%) |
| Sep 2024 | - | -$103.28M(-30.4%) | -$503.53M(+1.6%) |
| Jun 2024 | - | -$148.31M(+3.2%) | -$495.48M(+15.2%) |
| Mar 2024 | - | -$143.70M(+32.8%) | -$430.06M(+19.2%) |
| Dec 2023 | -$360.92M(+23.9%) | -$108.22M(+13.6%) | -$360.92M(+7.1%) |
| Sep 2023 | - | -$95.24M(+14.9%) | -$336.92M(+4.8%) |
| Jun 2023 | - | -$82.90M(+11.2%) | -$321.38M(+4.2%) |
| Mar 2023 | - | -$74.56M(-11.5%) | -$308.43M(+5.8%) |
| Dec 2022 | -$291.39M(+20.5%) | -$84.22M(+5.7%) | -$291.39M(+7.2%) |
| Sep 2022 | - | -$79.69M(+13.9%) | -$271.71M(+6.5%) |
| Jun 2022 | - | -$69.95M(+21.6%) | -$255.12M(+3.4%) |
| Mar 2022 | - | -$57.52M(-10.9%) | -$246.82M(+1.9%) |
| Dec 2021 | -$241.85M(+17.0%) | -$64.55M(+2.3%) | -$242.28M(+2.1%) |
| Sep 2021 | - | -$63.10M(+2.4%) | -$237.28M(+1.9%) |
| Jun 2021 | - | -$61.65M(+16.4%) | -$232.97M(+5.1%) |
| Mar 2021 | - | -$52.98M(-11.0%) | -$221.65M(+7.2%) |
| Dec 2020 | -$206.67M(+117.6%) | -$59.55M(+1.3%) | -$206.67M(+16.7%) |
| Sep 2020 | - | -$58.79M(+16.8%) | -$177.07M(+24.3%) |
| Jun 2020 | - | -$50.33M(+32.4%) | -$142.48M(+24.0%) |
| Mar 2020 | - | -$38.01M(+26.9%) | -$114.86M(+20.9%) |
| Dec 2019 | -$94.97M(+133.4%) | -$29.95M(+23.8%) | -$94.97M(+19.5%) |
| Sep 2019 | - | -$24.20M(+6.6%) | -$79.47M(+19.3%) |
| Jun 2019 | - | -$22.70M(+25.3%) | -$66.61M(+28.8%) |
| Mar 2019 | - | -$18.12M(+25.4%) | -$51.73M(+27.2%) |
| Dec 2018 | -$40.68M(+26.9%) | -$14.45M(+27.5%) | -$40.68M(+15.8%) |
| Sep 2018 | - | -$11.33M(+44.8%) | -$35.14M(+8.3%) |
| Jun 2018 | - | -$7.83M(+10.7%) | -$32.44M(-1.9%) |
| Mar 2018 | - | -$7.07M(-20.7%) | -$33.06M(+3.1%) |
| Dec 2017 | -$32.06M(+27.4%) | -$8.91M(+3.2%) | -$32.06M(+3.8%) |
| Sep 2017 | - | -$8.64M(+2.3%) | -$30.90M(-14.9%) |
| Jun 2017 | - | -$8.44M(+38.9%) | -$36.31M(+19.0%) |
| Mar 2017 | - | -$6.08M(-21.6%) | -$30.51M(+21.2%) |
| Dec 2016 | -$25.18M(+678.7%) | -$7.75M(-44.8%) | -$25.18M(+37.2%) |
| Sep 2016 | - | -$14.05M(+432.4%) | -$18.34M(+254.5%) |
| Jun 2016 | - | -$2.64M(+257.6%) | -$5.18M(-76.5%) |
| Mar 2016 | - | -$738.00K(-19.6%) | -$22.04M(-47.1%) |
| Dec 2015 | -$3.23M(-96.1%) | -$918.40K(+4.4%) | -$41.63M(-31.3%) |
| Sep 2015 | - | -$880.00K(-95.5%) | -$60.61M(-23.5%) |
| Jun 2015 | - | -$19.50M(-4.1%) | -$79.18M(-2.7%) |
| Mar 2015 | - | -$20.33M(+2.2%) | -$81.38M(-3.1%) |
| Dec 2014 | -$83.95M | -$19.89M(+2.3%) | -$83.95M(-4.1%) |
| Sep 2014 | - | -$19.45M(-10.4%) | -$87.50M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$21.70M(-5.3%) | -$89.85M(-0.4%) |
| Mar 2014 | - | -$22.91M(-2.3%) | -$90.21M(+3.0%) |
| Dec 2013 | -$87.56M(+43.7%) | -$23.44M(+7.6%) | -$87.56M(+7.0%) |
| Sep 2013 | - | -$21.79M(-1.2%) | -$81.82M(+9.7%) |
| Jun 2013 | - | -$22.06M(+8.9%) | -$74.56M(+11.9%) |
| Mar 2013 | - | -$20.26M(+14.4%) | -$66.63M(+9.3%) |
| Dec 2012 | -$60.94M(+34.1%) | -$17.70M(+21.8%) | -$60.94M(+14.0%) |
| Sep 2012 | - | -$14.54M(+2.9%) | -$53.48M(+4.5%) |
| Jun 2012 | - | -$14.13M(-3.0%) | -$51.16M(+4.3%) |
| Mar 2012 | - | -$14.56M(+42.3%) | -$49.03M(+7.9%) |
| Dec 2011 | -$45.43M(+23.1%) | -$10.24M(-16.2%) | -$45.43M(+4.3%) |
| Sep 2011 | - | -$12.22M(+1.7%) | -$43.56M(+4.8%) |
| Jun 2011 | - | -$12.01M(+9.5%) | -$41.57M(+7.7%) |
| Mar 2011 | - | -$10.97M(+31.1%) | -$38.61M(+4.6%) |
| Dec 2010 | -$36.90M(-145.8%) | -$8.37M(-18.2%) | -$36.90M(+3.9%) |
| Sep 2010 | - | -$10.23M(+13.1%) | -$35.51M(-138.2%) |
| Jun 2010 | - | -$9.04M(-2.3%) | $92.89M(-0.6%) |
| Mar 2010 | - | -$9.26M(+32.6%) | $93.48M(+16.1%) |
| Dec 2009 | $80.54M(-185.9%) | -$6.98M(-105.9%) | $80.54M(+30.6%) |
| Sep 2009 | - | $118.17M(-1498.0%) | $61.66M(-174.3%) |
| Jun 2009 | - | -$8.45M(-61.9%) | -$82.97M(-14.9%) |
| Mar 2009 | - | -$22.20M(-14.2%) | -$97.46M(+4.0%) |
| Dec 2008 | -$93.71M(+41.5%) | -$25.86M(-2.2%) | -$93.71M(+11.3%) |
| Sep 2008 | - | -$26.45M(+15.3%) | -$84.19M(+15.1%) |
| Jun 2008 | - | -$22.95M(+24.4%) | -$73.13M(+8.1%) |
| Mar 2008 | - | -$18.45M(+12.9%) | -$67.65M(+2.2%) |
| Dec 2007 | -$66.22M(+11.9%) | -$16.34M(+6.2%) | -$66.22M(+5.3%) |
| Sep 2007 | - | -$15.39M(-11.9%) | -$62.88M(+1.3%) |
| Jun 2007 | - | -$17.47M(+2.7%) | -$62.06M(+4.3%) |
| Mar 2007 | - | -$17.01M(+30.8%) | -$59.52M(+3.6%) |
| Dec 2006 | -$59.15M(-16.9%) | -$13.01M(-10.8%) | -$57.44M(-4.2%) |
| Sep 2006 | - | -$14.58M(-2.4%) | -$59.92M(-16.8%) |
| Jun 2006 | - | -$14.93M(0.0%) | -$72.03M(-14.0%) |
| Mar 2006 | - | -$14.93M(-3.6%) | -$83.79M(-4.1%) |
| Dec 2005 | -$71.18M(+57.0%) | -$15.49M(-41.9%) | -$87.36M(+21.6%) |
| Sep 2005 | - | -$26.69M(0.0%) | -$71.87M(+59.1%) |
| Jun 2005 | - | -$26.69M(+44.3%) | -$45.18M(+144.3%) |
| Mar 2005 | - | -$18.50M(+239.3%) | -$18.50M(+239.3%) |
| Dec 2004 | -$45.35M(+60.3%) | - | - |
| Mar 2004 | - | -$5.45M | -$5.45M |
| Dec 2003 | -$28.29M(+288.0%) | - | - |
| Dec 2002 | -$7.29M(+1718.5%) | - | - |
| Dec 2001 | -$401.00K | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual EBIT year-on-year change?
- What is Madrigal Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly EBIT year-on-year change?
- What is Madrigal Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM EBIT year-on-year change?
What is Madrigal Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of MDGL is -$451.22M
What is the all time high annual EBIT for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual earnings before interest & taxes is $80.54M
What is Madrigal Pharmaceuticals annual EBIT year-on-year change?
Over the past year, MDGL annual earnings before interest & taxes has changed by -$90.30M (-25.02%)
What is Madrigal Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of MDGL is -$69.94M
What is the all time high quarterly EBIT for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly earnings before interest & taxes is $118.17M
What is Madrigal Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, MDGL quarterly earnings before interest & taxes has changed by +$73.76M (+51.33%)
What is Madrigal Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of MDGL is -$377.46M
What is the all time high TTM EBIT for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM earnings before interest & taxes is $93.48M
What is Madrigal Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, MDGL TTM earnings before interest & taxes has changed by +$52.60M (+12.23%)